BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24588327)

  • 1. Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis.
    Lobach AR; Uetrecht J
    Chem Res Toxicol; 2014 Apr; 27(4):699-709. PubMed ID: 24588327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
    Maggs JL; Williams D; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
    Lai WG; Gardner I; Zahid N; Uetrecht JP
    Drug Metab Dispos; 2000 Mar; 28(3):255-63. PubMed ID: 10681368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo.
    Gardner I; Popović M; Zahid N; Uetrecht JP
    Chem Res Toxicol; 2005 Sep; 18(9):1384-94. PubMed ID: 16167830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo.
    Gardner I; Leeder JS; Chin T; Zahid N; Uetrecht JP
    Mol Pharmacol; 1998 Jun; 53(6):999-1008. PubMed ID: 9614201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis.
    Uetrecht JP; Zahid N; Whitfield D
    J Pharmacol Exp Ther; 1994 Sep; 270(3):865-72. PubMed ID: 7932198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase accumulates at the neutrophil surface and enhances cell metabolism and oxidant release during pregnancy.
    Kindzelskii AL; Clark AJ; Espinoza J; Maeda N; Aratani Y; Romero R; Petty HR
    Eur J Immunol; 2006 Jun; 36(6):1619-28. PubMed ID: 16688678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
    Iverson S; Zahid N; Uetrecht JP
    Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
    Ip J; Uetrecht JP
    Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Myeloperoxidase-Mediated N-Demethylation of Quetiapine Leads to
    Rashid MH; Babu D; Tran N; Reiz B; Siraki AG
    Chem Res Toxicol; 2022 Jun; 35(6):1001-1010. PubMed ID: 35575633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring an animal model of amodiaquine-induced liver injury in rats and mice.
    Liu F; Cai P; Metushi I; Li J; Nakayawa T; Vega L; Uetrecht J
    J Immunotoxicol; 2016 Sep; 13(5):694-712. PubMed ID: 27416278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis.
    Tschen AC; Rieder MJ; Oyewumi LK; Freeman DJ
    Clin Pharmacol Ther; 1999 May; 65(5):526-32. PubMed ID: 10340918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.
    Liu ZC; Uetrecht JP
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1476-83. PubMed ID: 8531118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase as a generator of drug free radicals.
    Uetrecht JP
    Biochem Soc Symp; 1995; 61():163-70. PubMed ID: 8660393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of clozapine by human neutrophils: evidence for a specific oxidation of clozapine by the myeloperoxidase system with inhibition of enzymatic chlorination cycle.
    Frimat B; Gressier B; Odou P; Brunet C; Dine T; Luycky M; Cazin M; Cazin JC
    Fundam Clin Pharmacol; 1997; 11(3):267-74. PubMed ID: 9243259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
    Ng W; Kennar R; Uetrecht J
    Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
    Li X; Cameron MD
    Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.
    Uetrecht JP
    Drug Saf; 1992; 7 Suppl 1():51-6. PubMed ID: 1503678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition.
    Ximenes VF; Kanegae MP; Rissato SR; Galhiane MS
    Arch Biochem Biophys; 2007 Jan; 457(2):134-41. PubMed ID: 17166480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features associated with reactive metabolite formation in clozapine analogues.
    Uetrecht J; Zahid N; Tehim A; Fu JM; Rakhit S
    Chem Biol Interact; 1997 May; 104(2-3):117-29. PubMed ID: 9212779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.